CDK9 inhibitors selectively target estrogen receptor-positive breast cancer cells through combined inhibition of<i>MYB</i>and<i>MCL-1</i>expression
Partha Mitra(University of Queensland), Thomas J. Gonda(University of Queensland)
Cited by 44
Related Papers
The mechanism of MYB transcriptional regulation by MLL-AF9 oncoprotein
|Scientific Reports|2019|10